|
Volumn 43, Issue 4, 2004, Pages 720-721
|
Smart Gene Therapy for the Heart
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEME OXYGENASE 1;
HYPOXIA INDUCIBLE FACTOR 1ALPHA;
OXYGEN;
PROTEIN BCL 2;
TRANSCRIPTION FACTOR GAL4;
BIOSENSOR;
DRUG EFFECT;
DRUG EFFICACY;
EDITORIAL;
ENZYME ACTIVITY;
GENE EXPRESSION REGULATION;
GENE THERAPY;
HEART INFARCTION;
HEART INFARCTION SIZE;
HYPOXEMIA;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
PROTEIN EXPRESSION;
STEM CELL;
TATA BOX;
APOPTOSIS;
BINDING SITES;
BIOSENSING TECHNIQUES;
CELL HYPOXIA;
GENE EXPRESSION REGULATION;
GENE THERAPY;
GENES, SYNTHETIC;
GENETIC VECTORS;
HEME OXYGENASE (DECYCLIZING);
HEME OXYGENASE-1;
HUMANS;
HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT;
MEMBRANE PROTEINS;
MYOCARDIAL INFARCTION;
MYOCARDIAL ISCHEMIA;
PLASMIDS;
PROTEIN STRUCTURE, TERTIARY;
PROTO-ONCOGENE PROTEINS C-BCL-2;
REGULATORY SEQUENCES, NUCLEIC ACID;
SACCHAROMYCES CEREVISIAE PROTEINS;
TATA BOX;
TRANS-ACTIVATION (GENETICS);
TRANSCRIPTION FACTORS;
|
EID: 1642460715
PISSN: 0194911X
EISSN: None
Source Type: Journal
DOI: 10.1161/01.HYP.0000120154.23084.41 Document Type: Editorial |
Times cited : (2)
|
References (11)
|